The cardiomyocyte circadian clock: emerging roles in health and disease - PubMed (original) (raw)

Review

The cardiomyocyte circadian clock: emerging roles in health and disease

David J Durgan et al. Circ Res. 2010.

Abstract

Circadian misalignment has been implicated in the development of obesity, diabetes mellitus, and cardiovascular disease. Time-of-day-dependent synchronization of organisms with their environment is mediated by circadian clocks. This cell autonomous mechanism has been identified within all cardiovascular-relevant cell types, including cardiomyocytes. Recent molecular- and genetic-based studies suggest that the cardiomyocyte circadian clock influences multiple myocardial processes, including transcription, signaling, growth, metabolism, and contractile function. Following an appreciation of its physiological roles, the cardiomyocyte circadian clock has recently been linked to the pathogenesis of heart disease in response to adverse stresses, such as ischemia/reperfusion, in animal models. The purpose of this review is therefore to highlight recent advances regarding the roles of the cardiomyocyte circadian clock in both myocardial physiology and pathophysiology (ie, health and disease).

PubMed Disclaimer

Figures

Figure 1

Integration of Metabolism within the Mammalian Circadian Clock. Figure summarizes a large number of distinct studies highlighting metabolic loops within the mammalian circadian clock (see section entitled Heart Metabolism). Solid lines represent direct effects/links; dashed lines represent multiple steps; dotted lines (with ‘?’) represent hypothetical links. Ac represents acetyl group on an acetylated protein; ProX represents an undefined protein. Other definitions are included in the List of Abbreviations.

Figure 2

Hypothetical Model for the Regulation of Myocardial I/R Tolerance by the Cardiomyocyte Circadian Clock. GSK-3β, in its dephosphorylated and active form, promotes mPTP opening in response to stresses such as ischemia/reperfusion, and subsequent cell death. Inhibition of GSK-3β, through Akt-mediated phosphorylation, for example, limits mPTP opening. Akt may also promote cardioprotection through GSK-3β independent mechanisms. The cardiomyocyte circadian clock modulates Akt and GSK3β activity, which potentially mediates time-of-day-dependent oscillations in myocardial ischemia/reperfusion tolerance.

Cited by

Circadian rhythms govern cardiac repolarization and arrhythmogenesis.
Jeyaraj D, Haldar SM, Wan X, McCauley MD, Ripperger JA, Hu K, Lu Y, Eapen BL, Sharma N, Ficker E, Cutler MJ, Gulick J, Sanbe A, Robbins J, Demolombe S, Kondratov RV, Shea SA, Albrecht U, Wehrens XH, Rosenbaum DS, Jain MK. Jeyaraj D, et al. Nature. 2012 Feb 22;483(7387):96-9. doi: 10.1038/nature10852. Nature. 2012. PMID: 22367544 Free PMC article.
Circadian regulation of sinoatrial nodal cell pacemaking function: Dissecting the roles of autonomic control, body temperature, and local circadian rhythmicity.
Li P, Kim JK. Li P, et al. PLoS Comput Biol. 2024 Feb 26;20(2):e1011907. doi: 10.1371/journal.pcbi.1011907. eCollection 2024 Feb. PLoS Comput Biol. 2024. PMID: 38408116 Free PMC article.
Association of accelerometer-derived circadian abnormalities and genetic risk with incidence of atrial fibrillation.
Yang L, Feng H, Ai S, Liu Y, Lei B, Chen J, Tan X, Benedict C, Wang N, Wing YK, Qi L, Zhang J. Yang L, et al. NPJ Digit Med. 2023 Mar 4;6(1):31. doi: 10.1038/s41746-023-00781-3. NPJ Digit Med. 2023. PMID: 36869222 Free PMC article.
Circadian rhythms and cancers: the intrinsic links and therapeutic potentials.
Zhou L, Zhang Z, Nice E, Huang C, Zhang W, Tang Y. Zhou L, et al. J Hematol Oncol. 2022 Mar 4;15(1):21. doi: 10.1186/s13045-022-01238-y. J Hematol Oncol. 2022. PMID: 35246220 Free PMC article. Review.
Cardiomyocyte-specific BMAL1 plays critical roles in metabolism, signaling, and maintenance of contractile function of the heart.
Young ME, Brewer RA, Peliciari-Garcia RA, Collins HE, He L, Birky TL, Peden BW, Thompson EG, Ammons BJ, Bray MS, Chatham JC, Wende AR, Yang Q, Chow CW, Martino TA, Gamble KL. Young ME, et al. J Biol Rhythms. 2014 Aug;29(4):257-76. doi: 10.1177/0748730414543141. J Biol Rhythms. 2014. PMID: 25238855 Free PMC article.

References

1. Smolensky MH, Portaluppi F. Ambulatory blood pressure monitoring. Application to clinical medicine and antihypertension medication trials. Ann N Y Acad Sci. 1996;783:278–294. - PubMed
1. McMullen JR, Jennings GL. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clin Exp Pharmacol Physiol. 2007;34(4):255–262. - PubMed
1. Edery I. Circadian rhythms in a nutshell. Physiol Genomics. 2000;3:59–74. - PubMed
1. Wilsbacher LD, Takahashi JS. Circadian rhythms: molecular basis of the clock. Curr Opin Genet Dev. 1998;8(5):595–602. - PubMed
1. Dunlap J. Molecular Basis of Circadian Clocks. Cell. 1999;96:271–290. - PubMed

The cardiomyocyte circadian clock: emerging roles in health and disease - PubMed (original) (raw)